Loading clinical trials...
Loading clinical trials...
A Randomized Phase II Trial Evaluation of the Addition of the Pediatric Cancer Resource Equity (PediCARE) Health Equity Intervention to Usual Supportive Care for Children With Newly Diagnosed High-Risk Neuroblastoma
Conditions
Interventions
PediCARE Intervention
Start Date
September 1, 2024
Primary Completion Date
September 1, 2028
Completion Date
September 1, 2028
Last Updated
August 5, 2024
NCT06721689
NCT04308330
NCT06541262
NCT06057948
NCT04936529
NCT06612645
Lead Sponsor
Dana-Farber Cancer Institute
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions